Authors
Latest:
The Project Management Institute's Pharmaceutical Specific Interest Group 2002 Benchmark Survey Results: Project Managers and Project Management in the Biotech Industryby Ellis Wilson, AstraZeneca Pharmaceuticals, James McDonough, William Allbee, and Jann Nielsen Compared with their big pharma counterparts, biotech project managers earn more advanced degrees, have fewer years' experience in the industry, and more frequently classify their role as "senior management."
Latest:
Small Biopharms Face Unique Challenges: Outsourcing in Early-Stage Drug Developmentby Bruce Babbitt, PAREXEL International, JanHasker Jonkman, and Paul McKim By partnering with external drug development service providers, small biopharmaceutical start-ups can move their products out of the lab and into clinical development more efficiently.
Latest:
Sialylation Levels Influence Oligosaccharide Quantitation: Analyzing Response Variability Using High-pH Anion-Exchange Chromatography and Pulsed Amperometric Detectionby Chandrashekar Ganesa, Genzyme Corporation, Brian W. Granda, and Robert J. Mattaliano
Latest:
Small Biopharms Face Unique Challenges: Outsourcing in Early-Stage Drug Developmentby Bruce Babbitt, PAREXEL International, JanHasker Jonkman, and Paul McKim By partnering with external drug development service providers, small biopharmaceutical start-ups can move their products out of the lab and into clinical development more efficiently.
Latest:
Collaborating Across the Extended Pharmaceutical Enterprise: How Sharing Information Leads to Process Enablementby Peter Loupos, Aventis Drug Innovation and Approval and Andrew Grygiel A collaborative framework can be a driver for cultural change, encouraging knowledge sharing between internal and external personnel and improving innovation and productivity throughout the enterprise.
Latest:
Collaborating Across the Extended Pharmaceutical Enterprise: How Sharing Information Leads to Process Enablementby Peter Loupos, Aventis Drug Innovation and Approval and Andrew Grygiel A collaborative framework can be a driver for cultural change, encouraging knowledge sharing between internal and external personnel and improving innovation and productivity throughout the enterprise.
Latest:
Sialylation Levels Influence Oligosaccharide Quantitation: Analyzing Response Variability Using High-pH Anion-Exchange Chromatography and Pulsed Amperometric Detectionby Chandrashekar Ganesa, Genzyme Corporation, Brian W. Granda, and Robert J. Mattaliano
Latest:
Survival Strategies: The Life Sciences Industry Turns to eLearningby Susan McLaughlin, Drug Information Association The Drug Information Association unveils the first in a series of professional development programs delivered through eLearning technologies to members worldwide.
Latest:
The Project Management Institute's Pharmaceutical Specific Interest Group 2002 Benchmark Survey Results: Project Managers and Project Management in the Biotech Industryby Ellis Wilson, AstraZeneca Pharmaceuticals, James McDonough, William Allbee, and Jann Nielsen Compared with their big pharma counterparts, biotech project managers earn more advanced degrees, have fewer years' experience in the industry, and more frequently classify their role as "senior management."
Latest:
Small Biopharms Face Unique Challenges: Outsourcing in Early-Stage Drug Developmentby Bruce Babbitt, PAREXEL International, JanHasker Jonkman, and Paul McKim By partnering with external drug development service providers, small biopharmaceutical start-ups can move their products out of the lab and into clinical development more efficiently.
Latest:
The Project Management Institute's Pharmaceutical Specific Interest Group 2002 Benchmark Survey Results: Project Managers and Project Management in the Biotech Industryby Ellis Wilson, AstraZeneca Pharmaceuticals, James McDonough, William Allbee, and Jann Nielsen Compared with their big pharma counterparts, biotech project managers earn more advanced degrees, have fewer years' experience in the industry, and more frequently classify their role as "senior management."
Latest:
BioPharm International's Virus Inactivation Series: A Prefaceby William N. Drohan, Clearant Inc. and Shirley I. Miekka
Latest:
BioTrends: M&A Malaiseby Desiree de Myer, BioPharm International Despite market conditions favorable to merger and acquisition activity, a frenzy of consolidations still hasn't taken place.
Latest:
BioPharm International's Virus Inactivation Series: A Prefaceby William N. Drohan, Clearant Inc. and Shirley I. Miekka
Latest:
Sialylation Levels Influence Oligosaccharide Quantitation: Analyzing Response Variability Using High-pH Anion-Exchange Chromatography and Pulsed Amperometric Detectionby Chandrashekar Ganesa, Genzyme Corporation, Brian W. Granda, and Robert J. Mattaliano
Latest:
Sponsor-CMO Conflict Management for Clinical-Phase BiologicsThe authors present the CMO's perspective on various potential sources of sponsor-CMO conflicts.
Latest:
Modular Cleanroom Facility TrendsModular construction, preassembled modules, and independent structures offer advantages for cleanroom users.
Latest:
Modular Cleanroom Facility TrendsModular construction, preassembled modules, and independent structures offer advantages for cleanroom users.
Latest:
Stirred-tank Bioreactors in Vaccine Development VideoIn this eBook, Eppendorf experts will give an overview of the most used vaccine platforms and discuss the important role of stirred-tank bioreactors in this life-saving field.
Latest:
Freeze-Thaw Performance and Robustness Assessment of Celsius FFT 6LA case study assesses freezing time and physical robustness under stress.
Latest:
The Impact of Disposables on Project Economics in a New Antibody Plant: A Case StudyA case study compares capital costs, operating expenses, and NPV for a new MAb plant.
Latest:
Faking ItDrug counterfeiting has become a major problem for the FDA today; a variety of solutions is needed.
Latest:
The Impact of Disposables on Project Economics in a New Antibody Plant: A Case StudyA case study compares capital costs, operating expenses, and NPV for a new MAb plant.
Latest:
The Impact of Disposables on Project Economics in a New Antibody Plant: A Case StudyA case study compares capital costs, operating expenses, and NPV for a new MAb plant.
Latest:
A New Paradigm in Drug DevelopmentThe changing regulatory and manufacturing environment is ushering in a new approach to drug development.
Latest:
Rapid Process Development for High Yield Plasmid DNA Fed-batch FermentationHow to reduce plasmid-mediated metabolic burden for higher yields.
Latest:
Rapid Process Development for High Yield Plasmid DNA Fed-batch FermentationHow to reduce plasmid-mediated metabolic burden for higher yields.
Latest:
Rapid Process Development for High Yield Plasmid DNA Fed-batch FermentationHow to reduce plasmid-mediated metabolic burden for higher yields.
Latest:
QbD and GMPs: How the Convergence of Science and Compliance Will Change the Way We WorkThe focus on the design space will lead to a new workspace, and will affect staff in the development, manufacturing, and quality functions.
Latest:
Finding the Balance in Managing the Quality and Efficiency of the Supply ChainAn enterprise-wide quality management initiative is required to maintain supplier quality without sacrificing bottom-line objectives.
